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Abstract
Accurate diagnosis of cutaneous leishmaniasis (CL) is important for chemotherapy and
epidemiological studies. Common approaches for Leishmania detection involve the inva-
sive collection of specimens for direct identification of amastigotes by microscopy and the
culturing of promastigotes from infected tissues. Although these techniques are highly
specific, they require highly skilled health workers and have the inherent risks of all inva-
sive procedures, such as pain and risk of bacterial and fungal super-infection. Therefore,
it is essential to reduce discomfort, potential infection and scarring caused by invasive
diagnostic approaches especially for children. In this report, we present a novel non-
invasive method, that is painless, rapid and user-friendly, using sequential tape strips for
sampling and isolation of DNA from the surface of active and healed skin lesions of CL
patients. A total of 119 patients suspected of suffering from cutaneous leishmaniasis with
different clinical manifestations were recruited and samples were collected both from
their lesions and from uninfected areas. In addition, 15 fungal-infected lesions and 54
areas of healthy skin were examined. The duration of sampling is short (less than one
minute) and species identification by PCR is highly specific and sensitive. The sequential
tape stripping sampling method is a sensitive, non-invasive and cost-effective alternative
to traditional diagnostic assays and it is suitable for field studies as well as for use in
health care centers.
Author summary
Cutaneous leishmaniasis is highly endemic in many countries and definitive diagnosis of
disease is crucial. Accurate diagnosis of cutaneous leishmaniasis requires isolation of
infected tissues, culturing of parasites from infected lesion and microscopic identification
of parasites. Both approaches are invasive and cause discomfort especially for children.
Here, we described a novel method using sequential tape strips for sampling and isolation
of DNA from the surface of skin lesions of CL patients for specific diagnosis. This method
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is a sensitive, non-invasive and cost-effective alternative to traditional diagnostic assays.
Furthermore, it is painless, rapid, user-friendly and suitable for field studies and heath
care centers.
Introduction
The leishmaniases are a complex of neglected tropical diseases affecting more than 12 million
people in 98 countries, with 350 million people at risk [1]. The clinical status of the disease can
be classified as localized cutaneous, mucocutaneous, diffuse and visceral leishmaniasis. Differ-
ent species of Leishmania are transmitted to the human host by the bite of infected female
sandfly vectors. Cutaneous leishmaniasis is endemic in 87 countries and caused by various spe-
cies of protozoan parasites of the genus Leishmania such as L. major, L. tropica, L. infantum, L.
aethiopica, L. mexicana, L. amazonensis and L. braziliensis. It is the most significant protozoan
infection in India, Central, South, and Western Asian countries as well as in countries sur-
rounding the Mediterranean Sea [2]. The annual incidence of CL is between 0.7 and 1.2 mil-
lion cases worldwide. The incidence may change from year to year and the actual number of
cases may not be accurate due to underreporting. There is no satisfactory treatment for any of
the different forms of CL [3]. Available treatments include pentavalent antimonials, sodium
stibogluconate (Pentostam, Stibanate) and meglumineantimoniate (Glucantime), which have
been used for over half a century [4].
Cutaneous leishmaniasis starts as a papule at the site of the sandfly bite and is usually associ-
ated with cell infiltration (induration), followed by ulceration and eventually re-epithelializa-
tion and scarring. Usually lesions heal in more than 90% of cases in a time span of 3–18
months [5]. The symptoms of leishmaniasis can vary and may be confused with skin diseases
caused by other etiological agents; therefore diagnostic confirmation of the parasite is manda-
tory for starting the specific treatment. For diagnosis of CL, parasitological detection is
essential and it is usually based on direct detection of amastigotes in smears from lesions by
microscopy and by the culturing of promastigotes from infected tissues [6–8]. Although these
techniques are highly specific, they are time consuming, require skilled health workers and are
not able to identify the causative strain of Leishmania. The ability to type the infecting Leish-
mania species is important for treatment and control measures as well for epidemiological
studies. A recent approach using polymerase chain reaction (PCR)-based methods for species
identification is a specific, sensitive and reliable alternative tool as compared to traditional
techniques [9–11]. Some available invasive techniques such as punch biopsies, scrapings and
aspirates of ulcers are among the most commonly used clinical specimen collection methods
for diagnosis of CL [12–15]. Besides requiring technical expertise, these invasive approaches
carry the risk of bleeding, pain as well as bacterial and fungal super-infections. Therefore,
non-invasive, painless, safer, simpler and more sensitive diagnostic procedures are urgently
required, especially for children.
In this study, we described the use of tape strip sampling as a non-invasive method for diag-
nosis and isolation of DNA from the surface of infected and non-infected areas of the skin of
CL patients. By using this non-invasive method, species identification can be performed in dif-
ferent stages of the disease including acute, chronic and healed lesions. Therefore, the use of
the non-invasive sampling technique described here will facilitate diagnosis of CL and identifi-
cation of the infecting Leishmania species.
Non-invasive diagnostic sampling for cutaneous leishmaniasis
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Methods
Ethics statement
The present study was approved by the Ethics Committee of the Pasteur Institute of Iran and
the Razi Skin Hospital affiliated with the Tehran University of Medical Sciences. All sampling
from CL patients was performed under the supervision of dermatologists at Razi Hospital and
the Emam Reza Hospital (Mashhad). Fungal skin sampling was carried out in the Mycology
Department at the Pasteur Institute of Iran. Sampling from the skin of healthy controls was
performed in different locations in Tehran and Mashhad. Sample collection from all the
different subjects was carried out by two well-trained research assistants in order to allow for a
comparable, uniform sampling approach. All participants signed the informed consent form
before sample collection. For children, the written informed consent form was signed by
parents or legal guardians on behalf of their children.
Patients and clinical samples
Patients from different health care centers were referred to the Skin Center of Razi Hospital
(Tehran) and the Emam Reza Hospital (Mashhad) for diagnosis of CL. Patients with clinical
appearance of erythematous nodules or ulcerated lesions with a minimal size of 1 cm in diame-
ter and a duration of more than one month were selected by a dermatologist. Positive diagno-
sis of CL (n = 119) was based on the microscopic detection of Leishmania parasites in Giemsa-
stained lesion smears. The duration of the disease was defined as starting from the time the
patients noticed the appearance of skin inflammation and lesions and the clinical and parasito-
logical confirmation of CL. Lesions were sampled from a total of 119 referred patients; 49 were
female, 70 were male and the median age was 30 years (average 33±20.27, range: minimum 1/
maximum 79 years old) as shown in Table 1. Specimens were obtained from the nose, lips,
ears, eyelids, chin, cheeks, neck, legs, arms, and fingers of the patients. It is worth to mention
that the sizes of lesion are different in different patients. Furthermore, 15 cases with fungal
infections of the skin were also included in this study. As negative controls, samples were col-
lected from the skin of 54 non-infected healthy individuals without previous history of CL.
Direct examination
The touch smear of dermal tissue of each patient was prepared by superficial incision on the
margin of the lesion against a glass microscope slide. After the smear had dried completely, it
Table 1. Clinical profiles of 119 cutaneous leishmaniasis patients.
Profiles
• Age (year)a 33±20.27
• Gender
Male 70(58%)
Female 49(42%)
• Average number of lesion 2.7±3.3
• Lesion site on
Lip 6(5%)
Eyelid 2(1.6%)
Ear 2(1.6%)
Other sites of face 32(26.6%)
Hand 40(33.3%)
Leg 17(14.1%)
Mix 21(17.5%)
https://doi.org/10.1371/journal.pntd.0005750.t001
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was fixed with absolute methanol and stained with Giemsa for microscopic examination for
presence of amastigote.
Study design
As a pilot study, thirty-one confirmed active CL cases were selected in order to compare the
sensitivity of two different approaches. For the invasive sampling approach, 2 mm biopsies
were collected from the border of ulcerated lesion using a sterile disposable punch. Each
biopsy was used to culture under the sterile condition for parasite propagation. For non-inva-
sive skin sampling, one tape disc (D-Squame, CuDerm Corporation, Texas, USA) with a diam-
eter of 22 mm was placed on an infected and uninfected area. For further validation, eighty-
eight new confirmed CL patients were diagnosed through non-invasive sampling.
Parasite culture
The fragmented biopsy from the border of the ulcers were collected and inoculated into
Schneider’s Drosophila medium (Sigma, Darmstadt, Germany), supplemented with 10% heat-
inactivated fetal bovine serum (FBS, Gibco, UK), 40 mM HEPES, 2 mM, 0.1 mM adenosine, 2
mM L-glutamine, 0.5μg/ml hemin (all from Sigma, Germany) and 50 μg/ml gentamicin (Bio-
sera, France) and incubated at 26˚C. Cultures were checked microscopically for live and motile
promastigotes for maximum of 3–4 weeks.
Tape strip sampling
For non-invasive skin sampling, one tape disc was placed on selected areas (infected and non-
infected areas). In order to apply even pressure to the disc, a plunger was gently held on the
selected areas and pressed for approximately 20 seconds as already reported [16,17]. The tape
disc was detached and transferred into a sterile 1.5ml vial and stored at 4˚C until further use.
This sampling is painless for patients, especially for children, and can be used to sample lesions
on sensitive parts such as eyelids and lips.
Isolation and DNA preparation from tape strip discs
In order to isolate the DNA from the tape disc, each strip was divided into eight pie-slice pieces
using sterile scissors and placed into a 1.5ml sterile vial. DNA samples were extracted using a
slightly modified DNAeasy Blood & Tissue kit (QIAGEN, Germany). To each sample tube
180μl of ATL BQ and 20μl proteinase K were added, gently mixed and incubated for 3 hours at
56˚C in a dry block. During incubation the mixture was gently vortexed every 30 minutes. The
rest of the steps were done according to the QIAGEN manual. DNA was eluted with 70μl H2O
and stored at 4˚C. The DNA concentration of each extraction was measured using a Nano-
Drop ND 1000 (5ng-35ng/μl). Genomic DNA from reference strains, L. major (MHRO/IR/75/
ER) and L. tropica (MOHM/IR/09/Khamesipour-Mashhad) were prepared following the man-
ufacturer’s instructions (QIAGEN, Germany).
PCR amplification and identification of parasite species
Two PCR assays were used in our experiments: First PCR was targeting the kDNA1 minicircle
of Leishmania species [18] and the second was for species identification (L. tropica and L.
major).
Amplification of kDNA1 minicircle for detection of conserved targets of Leishmania species
was performed by using a pair of primers F: GGGTAGGGGCGTTCTGC R: TACACCAACC
CCCAGTTTGC (Invitrogen). PCR mixtures contained 4mM MgCl2, 0.5mM dNTP, 1 Unit of
Non-invasive diagnostic sampling for cutaneous leishmaniasis
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Taq DNA polymerase (Roche, Germany) and 40ng of each primer in a final volume of 50μl.
Amplification conditions in an eppendorf thermocycler (Germany) were as follows: 95˚C for
5min, 62˚C for 1min, 72˚C for 1min, 95˚C for 45 sec, 65˚C for 30 sec, 72˚C for 30 sec (30
cycle), 72˚C for 5 min. Amplification products were subjected to electrophoresis in 1% agarose
in 0.5 X TBE (0.045M Tris-borate, 1mM EDTA) buffer. DNA purified from cultured promasti-
gotes of L. major and L. tropica as reference strains was amplified in each PCR experiment as
positive control. As negative controls we used water instead of DNA and amplified it in each
PCR experiment.
For species identification, the internal transcribed space 1 (ITS1) PCR assay was used with
primers LITSR (5´CTGGATCATTTTCCGATG3´) and L5.8S (5´ TGATACCACTTATCG
CACTT 3´) to amplify the ribosomal ITS1 region [19,20]. The DNA amplification was per-
formed in a 50μl reaction comprised of 0.5mM dNTP, 1.5mM MgCl2, 1U of Taq polymerase
(Roche, Germany), 25pmol of each primer and 10ng of DNA from each reference strain or
100-200ng DNA isolated from clinical samples and healthy controls. The cycling conditions
were 94˚C for 5min, followed by 35 cycles of 94˚C for 30sec, 53˚C for 1min, and 72˚C for
1min and final extension of 72˚C for 15min. Then the PCR products were subjected to RFLP
analysis by digesting the amplified PCR product with 1U HaeIII enzyme (Roche) at 37˚C for 2
hours. The restriction fragments were analyzed on 2% agarose gels.
Statistical analysis
Sensitivity comparisons of the sampling techniques used were performed on samples from 31
patients using biopsies, parasite culturing and the non-invasive tape strip disc sampling. The
sensitivity of each method was calculated based on the percentage of positivity of the total ana-
lyzed samples with 95% confidence interval for each approach. Level of significance was set at
p<0.05.
Results
Sampling and clinical profile of patients
In this study we used a tape stripping technique to sample the affected skin. As shown in Figs 1
and 2, skin sampling can be done in less than a minute and does not need to be performed by
highly trained individuals. The method we used is child-friendly, causes virtually no pain, and
is very practical for those lesions which occur in sensitive areas such as the eyelids, lips and
Fig 1. Schematic presentation of sampling lesions with tape strip discs, DNA isolation and further
identification of Leishmania species. 1) patient´s lesion 2) disc 3) disc applied to patient´s lesion 4) even
pressure applied on lesion using a plunger 5) sterile removal of disc from the lesion 6) DNA isolation from disc
7) confirmation of Leishmania by kDNA1 8) species-specific identification (PCR ITS-RFLP).
https://doi.org/10.1371/journal.pntd.0005750.g001
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ears, as shown in Fig 3. Of the 119 confirmed CL patients enrolled in this study, 79 patients
(66%) presented with acute CL (duration ranged from 1 up to 12 months), 32 (27%) with
chronic CL (duration ranged from 30 up to 360 months) and 8 (7%) with healed CL (recovered
for more than 6 months, 70 males and 49 females). The disease duration, gender distribution
and infecting species of Leishmania are shown in Table 2. In total, 71 patients were infected
with L. tropica (60%), 41 with L. major (34%) and 7 were undetermined (6%). In our project,
35% of the patients suffered from multiple lesions (more than 3) and the rest had only one
lesion as shown in Table 1.
Recovery of DNA from skin lesion and non-infected skin using
noninvasive stripping disc
In this study, we collected tape strip samples from both skin lesions and non-infected control
sites. Substantially more DNA was harvested from lesions as compared to control skin; an
average of 19.5 ng/μl (range: 7 to 34 ng/μl) of DNA was recovered from lesions and an average
of 1.9 ng/μl (range: 0.7 to 2.7 ng/μl) was isolated from the control skin sites as shown in Fig 4.
PCR and identification of Leishmania species collected using
noninvasive tape strip discs
In the first step, DNA isolated from all the collected tape strip disc samples, including CL-
patients with active, chronic or healed disease, fungal-infected patients and healthy skin, were
amplified using kDNA1 minicircle primers. The kDNA1 amplification was positive for all CL
Fig 2. Illustration of sample collection using tape strip disc. A) determine the lesion for disc sampling B)
apply the tape strip disc on the lesion C) apply even pressure for 20 seconds with the plunger D) detach the
disc and transfer into a sterile vial for DNA isolation.
https://doi.org/10.1371/journal.pntd.0005750.g002
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patients and yielded 100% sensitivity as shown in Fig 5A. In contrast, none of the samples
from patients infected with fungi nor those from healthy skin were positive using the kDNA1
minicircle primers. Standard reference strains of L. major and L. tropica were used as positive
controls. In the second step, all isolated DNA with positive amplification using kDNA1 were
subjected to ITS1 PCR-RFLP for species identification. Standard strains of L. major and L. tro-
pica were used as controls. PCR to amplify the ITS1 region gave an amplified fragment of
300bp for all samples from CL patients. Subsequent digestion with the restriction enzyme
HaeIII revealed two bands for L. major (160 and 210bp) and L. tropica (50 and 190bp) Fig 5B.
Among the 79 acute cases, 45 samples (57%) were diagnosed as L. tropica, 30 samples (38%) as
L. major and 4 cases (5%) were not amplified with ITS1 primers, as shown in Table 2. From 32
chronic CL cases, 18 samples (56.4%) were diagnosed as L. tropica, 11 cases (34.3%) as L.
major and 3 samples (9.3%) were not amplified with ITS1 primers. Among the 8 healed sam-
ples, 7 samples were diagnosed as L. tropica and one sample as L. major. Using ITS1 primers, a
total of 112 samples were diagnosed as either L. major or L.tropica and showed 94% sensitivity.
Diagnosis using the non-invasive tape strip disc technique is more
sensitive than parasite culture
We compared the sensitivity of the two different diagnostic techniques based on either cultur-
ing parasites from the biopsies obtained from 31 confirmed CL patients or based on the non-
invasive tape strip disc technique. As shown in Table 3, the diagnostic accuracy of each method
was calculated separately as compared to microscopic identification of amastigotes in lesion
Table 2. Disease duration, gender distribution and infecting species of Leishmania in CL patients with acute, chronic or healed disease.
Female Male Mean duration in month (min-max) % L. tropica infected % L. major Infected Unknown species
Acute CL N = 79 31 (39%) 48 (61%) 5.8 (1–12) 45 (57%) 30 (38%) 4 (5%)
Chronic CL N = 32 15 (47%) 17 (53%) 75.8 (30–360) 18 (56.4%) 11 (34.3%) 3 (9.3%)
Healed CL N = 8 3 (37%) 5 (63%) 9.4 (6–12) 7 (87%) 1 (13%) 0
Total N = 119 49 (42%) 70 (58%) 71 (60%) 41 (34%) 7 (6%)
https://doi.org/10.1371/journal.pntd.0005750.t002
Fig 3. Sensitive areas for sampling. A) eyelid B) around the eye C) ear D) on the lips.
https://doi.org/10.1371/journal.pntd.0005750.g003
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smears as a diagnostic reference standard. The highest diagnostic sensitivity of 100% (95% CI)
was achieved with the tape strip disc technique. Of 31 suspected patients, only 16 were positive
for culturing parasite from lesion biopsies (sensitivity 51%) which was significantly lower than
tape strip disc sampling (p<0.05).
Discussion
Here we present a non-invasive technique for sampling different clinical stages of CL lesions
including those from patients with acute, chronic and healed lesions. Tape strip disc sampling
is non-invasive, easy to perform, and well tolerated by patients compared to traditional diag-
nostic methods such as biopsy, aspiration and scraping. In countries where leishmaniasis is
highly endemic, the rate of infected children is high and, sometimes due to fear, it is not
Fig 4. Genomic DNA isolation from healthy and infected skin. The concentration of DNA from healthy
skin is lower (lanes 1–3, mean 1.9 ng/μl) as compared to infected skin (lanes 4–10, mean 19.5 ng/μl)
https://doi.org/10.1371/journal.pntd.0005750.g004
Fig 5. Agarose gel electrophoresis of amplified ITS1 regions of standard reference strains. L. major
(lane 1) and L. tropica (lane 2) and from CL patients (lanes 3–9) in panel A and restriction endonuclease
HaeIII digestion is shown in panel B. In both panels, MW representative of 100-bp ladder as molecular size
marker. Patients in samples 3, 4, 6, 7 and 9 are infected with L. tropica and patients in samples 5 and 8 are
infected with L. major.
https://doi.org/10.1371/journal.pntd.0005750.g005
Table 3. Diagnostic accuracy of parasite culture from biopsies and tape strip disc.
Sample Type* TP FP FN TN Sensitivity (95% CI)
Biopsy Culture 16 0 15 0 51% (33% - 69%)
Tape Strip Disc 31 0 0 0 100%
*Compared with the reference microscopy diagnostic test (TP, true positive; FP, false positive; FN, false
negative; TN, true negative; CI, confidence interval)
https://doi.org/10.1371/journal.pntd.0005750.t003
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possible to take samples for diagnostic and follow-up purposes. This alternative, non-invasive
sampling technique is patient-friendly and was acceptable to all children involved in this proj-
ect. The presented non-invasive approach also eliminates the risk of scarring, and co-infec-
tions and reduces the costs associated with biopsy, infection or wound care. By using this
novel approach for CL sampling, we were able to bypass several intermediary steps and elimi-
nate the need for anesthetic, needles, syringes and sharp biohazard disposal. Many other tech-
niques, such as aspirating and scraping the CL lesion, are highly operator dependent requiring
a trained clinician/health care worker for sampling and are difficult to perform routinely in
remote endemic areas. The tape strip disc sampling technique is applicable for use in remote
endemic areas and permits the easy transfer of the disc to a larger laboratory or reference cen-
ter for evaluation. The time for sample collection is less than a minute, which is very important
for field studies where large-scale sampling is done. Furthermore, the non-invasive tape strip
disc sampling could act as an attractive alternative not only for diagnosis of CL but also for
monitoring the response of patients to treatment. Recently, Suarez et al. reported a higher par-
asite load in samples collected using cytology brushes and dermal scrapings as compared to
biopsies [21]. This can be explained by the fact that Leishmania amastigotes are not homoge-
nously distributed in skin lesions and a higher abundance of parasites are in the upper layer of
the dermis. In addition, in a skin punch biopsy, the ratio of human host DNA to parasite DNA
is several fold higher compared to methods of scraping and using cytology brushes. These two
factors can decrease the sensitivity of detection of the pathogen in clinical samples.
Patients with different confirmed clinical stages of CL and different duration of skin lesions
as well as sizes (small to large lesions) and types (ulcerated, non ulcerated, dry, wet) were
recruited into this study and our results show that the novel sampling technique we used is
very sensitive; we not only detected parasites in tape strip discs in the acute stage of CL, where
most CL patients have ulcerative lesions with a high degree of parasite load, we also obtained
similar sensitivity in CL patients presenting with chronic lesions that harbour a lower parasite
load. The specificity of culturing parasites from biopsies is very high almost 100% but the sen-
sitivity is insufficient. By comparing the sensitivity of the invasive method of parasite culturing
from biopsies with non-invasive tape disc in limited number of active CL cases (n = 31), we
revealed significantly lower sensitivity for the invasive biopsy based technique (p<0.05). There
are different factors that may influence the sensitivity of culturing parasites from biopsies
including the strain and viability of collected parasites, the media (different requirement for
different species), the presence of a super infection and the expertise of the investigator. Differ-
ent success rates have been reported mostly between 40–50%. There are some reports showing
that swabs and cytology brush samples of CL are more sensitive than lesion aspirate and biopsy
samples [22]. Furthermore, the combination of swabs with quantitative PCR (qPCR) is emerg-
ing as powerful diagnostic tools due to its noninvasive and simple collection method [23].
Although we did not quantify the parasite load in the lesions of CL patients diagnosed by
the use of the noninvasive tape strip disc technique, it will be feasible to do this in future stud-
ies since the total amount of recovered DNA is sufficient to be used with more precise meth-
ods, such as quantitative real time PCR. Therefore, this non-invasive sampling method could
not only be used to improve diagnosis of CL, but also to quantify parasite burden in lesions of
CL patients. As reported by Prina et al [24], the Leishmania DNA detected by PCR is derived
from intact parasites and a positive PCR result was correlated to the presence of living para-
sites. There are other studies that show positive PCR results correspond to viable parasites in
infections caused by other protozoan parasites such as Plasmodium chabaudi, and Toxoplasma
gondii [25,26].
In the present study, we easily obtained enough DNA material from 119 CL patients, 15
fungal lesions as well as 54 samples of normal skin for PCR performance using different sets of
Non-invasive diagnostic sampling for cutaneous leishmaniasis
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primers to confirm the Leishmania infection and then identify the species in individuals with
both acute and chronic disease. Furthermore, we confirmed, in a limited number of healed
individuals, the Leishmania species. This may require further investigation for both New and
Old world leishmaniasis in different countries but promises to open new perspectives for non-
invasive diagnosis and epidemiological surveys.
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